Zivo Bioscience Stock Z Score
ZIVODelisted Stock | USD 1.10 0.08 6.78% |
Zivo |
Zivo Bioscience Company Z Score Analysis
Zivo Bioscience's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Zivo Bioscience Z Score | -87.31 |
Most of Zivo Bioscience's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zivo Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionAs per the company's disclosures, Zivo Bioscience has a Z Score of -87.31. This is 1393.48% lower than that of the Personal Care Products sector and notably lower than that of the Consumer Staples industry. The z score for all United States stocks is notably higher than that of the company.
Zivo Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zivo Bioscience's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zivo Bioscience could also be used in its relative valuation, which is a method of valuing Zivo Bioscience by comparing valuation metrics of similar companies.Zivo Bioscience is currently under evaluation in z score category among related companies.
Zivo Fundamentals
Return On Equity | -39.56 | ||||
Return On Asset | -1.65 | ||||
Operating Margin | (133.25) % | ||||
Current Valuation | 2.02 M | ||||
Shares Outstanding | 1.82 M | ||||
Shares Owned By Insiders | 25.23 % | ||||
Shares Owned By Institutions | 4.44 % | ||||
Number Of Shares Shorted | 35.47 K | ||||
Price To Earning | (1.95) X | ||||
Price To Book | 17.86 X | ||||
Price To Sales | 2,639 X | ||||
Gross Profit | 20 K | ||||
EBITDA | (8.73 M) | ||||
Net Income | (8.75 M) | ||||
Cash And Equivalents | 5.08 M | ||||
Cash Per Share | 0.54 X | ||||
Total Debt | 445.18 K | ||||
Debt To Equity | 0.28 % | ||||
Current Ratio | 2.08 X | ||||
Book Value Per Share | (0.63) X | ||||
Cash Flow From Operations | (7.1 M) | ||||
Short Ratio | 6.65 X | ||||
Earnings Per Share | (5.33) X | ||||
Target Price | 36.0 | ||||
Beta | 0.27 | ||||
Market Capitalization | 2 M | ||||
Total Asset | 2.12 M | ||||
Retained Earnings | (115.8 M) | ||||
Working Capital | (126.04 K) | ||||
Current Asset | 28.93 K | ||||
Current Liabilities | 4.97 M | ||||
Z Score | -87.31 | ||||
Annual Yield | 0.04 % | ||||
Net Asset | 2.12 M |
About Zivo Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zivo Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zivo Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zivo Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Zivo Bioscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Zivo Bioscience's short interest history, or implied volatility extrapolated from Zivo Bioscience options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Zivo Stock
If you are still planning to invest in Zivo Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |